Related Experiment Video
Updated: Oct 1, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Signaling pathway of cardioprotection induced by monophosphoryl lipid A in rabbit myocardium
Liu Xiuhua1, Wu Xudong, Han Yue
1Department of Pathophysiology, PLA General Hospital, 28 Fuxing Road, 100853, Beijing, PR China
Abstract:
OBJECTIVE: To investigate the effect of monophosphoryl lipid A (MLA) on ischemia/reperfusion (I/R) injury in rabbit heart and its signal transduction pathway. METHODS: Eighteen rabbits were randomly assigned to three groups: (1) MLA-group: Six rabbits received injection of MLA (35 &mgr;g/kg, iv) 24 h prior to 45 min of ischemia followed by 60 min of reperfusion. (2) Control group: Six rabbits received an intravenous bolus injection of the same volume of vehicle. (3) SB group: Six rabbits intravenously received 2 &mgr;mol/l SB 203580 30-min prior to MLA administration. At the end of reperfusion, myocardial infarct size and serum nitrite/nitrate were detected. Myocardium p38 mitogen-activated protein kinase (p38 MAPK) was detected using a Western blotting method. RESULTS: MLA pretreatment caused a significant reduction of infarct size as percent of area at risk as compared to vehicle-pretreated controls (36+/-3 vs. 65+/-4%, P<0.001). Total nitrite in serum increased in MLA pretreated animals (P<0.05). The protective effects of MLA were completely abolished by selective p38 MAPK inhibitor SB 203580. Western blot analysis showed significant accumulations of p38 MAPK proteins in the myocardium of MLA pretreated animals. CONCLUSIONS: MLA can protect the heart by reducing myocardial infarct size in rabbits. This cardioprotective effect might be attributed to upregulation of nitric oxide (NO) through the activation of p38 MAPK.
Insights
Monophosphoryl lipid A (MLA) significantly reduces heart damage from ischemia/reperfusion (I/R) injury in rabbits. This cardioprotective effect is linked to increased nitric oxide (NO) via p38 MAPK activation.
Area of Science:
- Cardiology
- Immunology
- Molecular Biology
Background:
- Ischemia/reperfusion (I/R) injury is a major cause of heart damage.
- Monophosphoryl lipid A (MLA) is an immune modulator with potential therapeutic applications.
- Understanding the signaling pathways involved in I/R injury is crucial for developing treatments.
Purpose of the Study:
- To investigate the cardioprotective effects of MLA against I/R injury in a rabbit model.
- To elucidate the role of the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway in MLA-mediated protection.
Main Methods:
- Rabbit hearts were subjected to 45 minutes of ischemia followed by 60 minutes of reperfusion.
- MLA was administered 24 hours prior to ischemia; a p38 MAPK inhibitor (SB 203580) was used to block the pathway.
- Myocardial infarct size, serum nitrite/nitrate levels, and myocardial p38 MAPK protein expression were assessed.
Main Results:
- MLA pretreatment significantly reduced infarct size (36% vs. 65% in controls, P<0.001).
- Serum nitrite/nitrate levels increased in MLA-treated rabbits.
- The protective effect of MLA was abolished by SB 203580, and p38 MAPK protein levels were elevated in MLA-treated myocardium.
Conclusions:
- MLA demonstrates significant cardioprotection against I/R injury in rabbits.
- The cardioprotective mechanism involves the upregulation of nitric oxide (NO) through the activation of the p38 MAPK pathway.
- MLA holds potential as a therapeutic agent for mitigating myocardial damage.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers